Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Afya (AFYA) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Afya (AFYA) over the last 9 years, with Q3 2025 value amounting to $167.3 million.

  • Afya's Cash & Equivalents rose 6772.01% to $167.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.3 million, marking a year-over-year increase of 6772.01%. This contributed to the annual value of $156.8 million for FY2024, which is 4032.69% up from last year.
  • According to the latest figures from Q3 2025, Afya's Cash & Equivalents is $167.3 million, which was up 6772.01% from $160.9 million recorded in Q2 2025.
  • Afya's 5-year Cash & Equivalents high stood at $224.0 million for Q3 2023, and its period low was $99.7 million during Q3 2024.
  • For the 5-year period, Afya's Cash & Equivalents averaged around $162.2 million, with its median value being $156.8 million (2024).
  • As far as peak fluctuations go, Afya's Cash & Equivalents crashed by 5547.62% in 2024, and later skyrocketed by 6772.01% in 2025.
  • Quarter analysis of 5 years shows Afya's Cash & Equivalents stood at $187.4 million in 2021, then fell by 24.05% to $142.3 million in 2022, then fell by 21.49% to $111.7 million in 2023, then soared by 40.33% to $156.8 million in 2024, then increased by 6.71% to $167.3 million in 2025.
  • Its Cash & Equivalents was $167.3 million in Q3 2025, compared to $160.9 million in Q2 2025 and $155.5 million in Q1 2025.